| Literature DB >> 27453708 |
Ewelina Kozioł1, Krystyna Skalicka-Woźniak1.
Abstract
Imperatorin, a furanocoumarin derivative, has many documented pharmacological properties which make it a candidate for possible drug development. In this review, the activity on the central nervous system, the anticancer and antiviral properties and the influence on the cardiovascular system are described. The aim of this review is also to present an overview of the techniques used for the analysis, isolation, and separation of imperatorin from plant material from the practical perspective.Entities:
Keywords: Furanocoumarin; Imperatorin; Psoralen derivatives
Year: 2016 PMID: 27453708 PMCID: PMC4939159 DOI: 10.1007/s11101-016-9456-2
Source DB: PubMed Journal: Phytochem Rev ISSN: 1568-7767 Impact factor: 5.374
Fig. 1The molecular structure of imperatorin (Cox et al. 2003)
Fig. 2Intra- and intermolecular interactions between molecules of imperatorin in the crystal lattice (Cox et al. 2003)
Plants containing imperatorin as an important constituent and their traditional use
| Species | Family | Occurrence | Traditional use |
|---|---|---|---|
|
| Apiaceae | East Russia, Asia | For headache, toothache, nose congestion resulting from cold, analgesia, acne, ulcers, carbuncle, rheumatism, as sedative (Baek et al. |
|
| Apiaceae | China, Japan, Canada and America | As a tonic, antiphlogistic and mucolytic medicine for the treatment of respiratory and gastrointestinal disorders, as diaphoretic, antipyretic, analgesic, antibacterial, and antifungal (Yang et al. |
|
| Apiaceae | Colombia | For dysentery, colitis and rheumatism (Duan et al. |
|
| Apiaceae | South Korea | For cold, headache, neuralgia and arthritis (Lee et al. |
|
| Apiaceae | South and Middle Europe, Croatia | As an insect repellent (Hadaček et al. |
|
| Apiaceae | Alpine region | In gastro-intestinal diseases, and also for disorders of the cardiovascular system, the respiratory tract, and to treat tiredness (Vogl et al. |
|
| Apiaceae | South China | As an antipyretic, analgesic and diaphoretic (Xiao et al. |
|
| Apiaceae | North India, Central Asia | As an emollient, carminative, tonic, antiflatulent, anthelmintic, antifungal, and antibacterial (Banday et al. |
|
| Apiaceae | Eastern Turkey | For bleeding and to heal scars (Ulubelen et al. |
|
| Apiaceae | China | For pyrexia, rheumatism, headache and convulsions (Kang et al. |
|
| Compositae | Asia, Europe, North America | For anthrax, apoplexy, rheumatic arthritis and altitude sickness (Dawa et al. |
|
| Rutaceae | Southeast Asia | In the treatment of malaria, diabetes, dyspepsia, constipation and body heating problems (Mishra et al. |
|
| Rutaceae | West Africa | As an insect repellent (Ngadjui et al. |
|
| Rutaceae | Southeast Asia | For coughs and colds, asthma, gastrointestinal diseases, influenza, abdominal colic pains, as an antifungal, antiproliferative, and HIV reverse transcriptase inhibitor (Maneerat et al. |
|
| Rutaceae | Southeast Mexico | For gastrointestinal ailments (Mata et al. |
|
| Rutaceae | Colombia and Venezuela | As an allelopathic agent inhibiting germination and root length of competing species such as lettuce, tomato, cucumber, and radish (Macías et al. |
|
| Rutaceae | Eastern Asia | In treating allergic diseases, as an anti-inflammatory, anti-bacterial and anti-mucin releasing (Xu et al. |
|
| Rutaceae | Mexico (Oaxaca and Yucatan), Costa Rica and Panama | As an insect repellent (Setzer et al. |
Examples of TCM remedies containing imperatorin
| Name of the TCM | Country | Pharmacological use |
|---|---|---|
| Oyaksungisan | Korea | For rheumatoid arthritis, paralysis and stroke, as an anti-inflammatory and analgesic, for relaxant activity in hypertension (Weon et al. |
| Ru-Yi-Jin-Huang-San | China | For reducing swelling, removing poisons, and relieving pain (Lay et al. |
| HouxiangZhengqi liquid | China | For reducing swelling, removing poisons, relieving pain (Li et al. |
| Yigong | China | In vigorating vital energy, to prolong and/or irregular menstruation (Feng et al. |
| Qianghuo | China | As a diaphoretic, antifebrile and anodyne (Jiang et al. |
|
| China | For impotence, frigidity, skin-related diseases, as an antiallergic, antidermatophytic, antibacterial, antifungal, antiosteoporotic (Li and Chen |
Application of CCC in isolation of imperatorin
| Plant material and the amount of extract subjected to purification | Two-phase solvent system | Amount and purity of isolated imperatorin | References |
|---|---|---|---|
|
| Multidimentional CCC: | 19.9 mg | Wei and Ito ( |
|
| Gradient extraction: | 29 mg | Liu et al. ( |
|
|
| 18.5 mg | Wei et al. ( |
|
| Heptane-ethyl acetate-methanol-water | 95 mg | Budzynska et al. ( |
|
| Stepwise elution: | 118.3 mg | Li and Chen ( |
|
| Stepwise elution: | 60.5 mg | Liu et al. ( |
|
|
| 56 mg | Urbain et al. ( |
Examples of the analysis of imperatorin in plant extracts by TLC
| Plant extract | Adsorbent | Solvent system | Detection | References |
|---|---|---|---|---|
|
| ||||
|
| HPTLC LiChrospher Si 60 F254S | Dichloromethane:heptan (1:11 | 313 and 365 nm | Hawryl et al. ( |
|
| Silica gel 60 F254 | Toluene:ethylacetate:glacial acetic acid (9:1:0.1) | 254 and 366 nm and after spraying with anisaldehyde/sulfuric acid reagent | Zschocke et al. ( |
|
| Silica gel |
| 365 nm | Zgórka ( |
|
| Florisil |
| 365 nm | Zgórka ( |
|
| ||||
|
| Silica gel (Merck) | 1st direction benzene: chloroform: acetonitrile (1:1 | 0.5 % I dissolved in KI Dragendorf’s reagent 25 % SbCl5 in CCl4 UV | Bogucka-Kocka ( |
| 2nd direction benzene:ethyl acetate (1:1 | ||||
| Coumarin mixtures isolated from plants in the genus | TLC and HPTLC silica gel 60 F254 plates | 1st direction chloroform (100 %) for 55 min 2nd direction | 254, 366 nm | Härmälä et al. ( |
The most useful combinations of solvent systems for the HPLC analysis of imperatorin
| Plant extract | Adsorbent | Solvent system | Flow rate (ml min−1) | Retention time (min) | References |
|---|---|---|---|---|---|
|
| Kromasil C18 250 × 4.6 mm; 5 µm column with 5 µm C-18 guard | Methanol:water 66:34 ( | 0.8 | 18 | Wang et al. ( |
|
| Polaris ODS 250 × 4.6 mm ID | Methanol:water 60:40 ( | 1 | 10 | Wei et al. ( |
|
| YMC ODS-C18 column 250 × 4.6 mm; 5 µm | Linear gradient elution: 20–24 % A (0–10 min); 24–40 % A (10–40 min); 40–52 % A (40–60 min); 52–72 % A (60–90 min)—A (acetonitrile-methanol = 5:3) and B—water | 1 | 43.07 | Xie et al. ( |
|
| Zorbax SB-C18 column 4.6 mm i.d. × 150 mm, 5 µm | Gradient: 10–30 % over 0–15 min, 30–90 % over 15–30 min, 30 % at 30 min of 0.1 % phosphoric acid and acetonitrile | 1 | 12 | Zhou et al. ( |
|
| Merck Chromolith™ RP-18e column 100 × 4.6 mm | Gradient elution: 20–80 (A:B) for 5 min, followed by a linear gradient to 28–72 in 0.5 min, maintained at 28–72 for 6.5 min, followed by a linear gradient to 30–70 in 0.5 min, maintained at 30–70 for 7.5 min, followed by a linear gradient to 32–68 in 0.1 min, and maintained at 32–68 for 40 min. A—acetonitrile and B—water containing 1 % ( | 2 | 51.16 | Teng et al. ( |
|
| Hypersil BDS C18 250 × 4.6 mm; 5 μm | Gradient: 50–60 % A (0–5 min); 60–80 % A (5–25 min); isocratic 80 % A (25–30 min); 80–100 % A (30–40 min). A—methanol, B—water | 1 | 16.74 | Skalicka-Woźniak and Głowniak ( |
|
| Hypersil ODS column (200 mm × 4.6 mm; 5 μm) | Acetonitrile: water 60:40 | 1 | Not provided | Zgórka and Głowniak ( |
|
| SUPELCOSIL™ LC18 150 × 4.6 mm; 5 μm | Gradient elution: 45 % methanol (0–10 min); 45–55 % methanol (10–20 min); 55–70 % methanol (20–30 min); 70 % methanol in water (30–40 min) | 1 | 32 | Waksmundzka-Hajnos et al. ( |
|
| Zorbax Rx C18 250 × 4.6 mm; 5 μm | Gradient: 85 % water (3 min), 80 % water (2 min), 70 % water (10 min), 55 % water (3 min), 50 % water (7 min), 30 % water(10 min), 15 % water (3 min), 5 % water (5 min). Water: acetonitrile solvent with 0.01 % acetic acid or 1 mM NH4OAc | 1 | 35 | Ganzera et al. ( |
|
| RP-18 150 × 4 mm; 3.9 μm | Gradient of methanol and water: 25–75 to 100–0 containing 0.05 % trifluoroacetic acid during 25 min, followed by 5 min with 100 % methanol | 1 | Urbain et al. ( | |
|
| RP-18 prodigy 100 × 4.6 mm; 3.0 μm | Methanol: 1 % formic acid 60:40 ( | 1 | 23.1 | Eeva et al. ( |
Fig. 3UV–DAD spectrum of imperatorin (Kim et al. 2011)
Fig. 4The mass spectral fragmentation pattern of imperatorin (Yang et al. 2010)
Examples of patents with imperatorin as the compound of interest
| Patent title | Number | Country |
|---|---|---|
| Pharmaceutical application of imperatorin in treatment of hypertension complicated with myocardial hypertrophy and heart protection | CN102349891 (A)—2012-02-15 | China (He |
| Furanocoumarin compounds with antihypertensive activity and preparation methods thereof | WO2011160597 (A1)—2011-12-29 | China (He |
| Novel inexpensive and efficient process for isolation of imperatorin, a potent inducible nitric oxide synthase inhibitor and anti-inflammatory drug candidate from | US20050220913 A1 | USA (Ponnapalli Mangala |